Close this search box.
Subscriber Log In

Evaluating the Cell and Gene Therapy Landscape

Recent years have seen significant developments in the landscape of cell and gene therapies, with a notable increase in treatments available for rare and life-threatening diseases. These advancements come despite the generally high costs of research, development and manufacturing, compounded by the relative infancy of our understanding compared to other scientific domains.

Get data-driven insights on the current and future state of the cell and gene therapy landscape in Evaluate’s new report.

We investigate:

  • Newly approved therapies and ongoing developments in the pipeline
  • Focus areas: Indications receiving the most attention
  • Competitive dynamics: Biotech vs. Big Pharma
  • Current appetite for partnerships
  • Future revenue drivers: Key therapies and disease areas


Related Blogs

Understand the context. Data-driven news and analysis for the pharma, biotech and medtech sectors.